There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- The New Rutgers School of Medicine Releases Mission, Vision and Values Statement Focused on Advancing Health Equity.
- Screen Time Is a Poor Predictor of Suicide Risk, Rutger Researchers Find.
- NJIT Robotics Expert Talks Drones as the University Researches Them.
- Rutgers Health Forms Corps to Clear the Air About Asthma.
- New NJACTS Publication
Categories
- News (2,320)
- Publication (1)